These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 31551443

  • 1. Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes.
    Fleszar MG, Wiśniewski J, Zboch M, Diakowska D, Gamian A, Krzystek-Korpacka M.
    Sci Rep; 2019 Sep 24; 9(1):13764. PubMed ID: 31551443
    [Abstract] [Full Text] [Related]

  • 2. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M, Wiśniewski J, Fleszar MG, Bednarz-Misa I, Bronowicka-Szydełko A, Gacka M, Masłowski L, Kędzior K, Witkiewicz W, Gamian A.
    Oxid Med Cell Longev; 2019 Sep 24; 2019():5965721. PubMed ID: 31396302
    [Abstract] [Full Text] [Related]

  • 3. Quantitative Analysis of l-Arginine, Dimethylated Arginine Derivatives, l-Citrulline, and Dimethylamine in Human Serum Using Liquid Chromatography-Mass Spectrometric Method.
    Fleszar MG, Wiśniewski J, Krzystek-Korpacka M, Misiak B, Frydecka D, Piechowicz J, Lorenc-Kukuła K, Gamian A.
    Chromatographia; 2018 Sep 24; 81(6):911-921. PubMed ID: 29887621
    [Abstract] [Full Text] [Related]

  • 4. A novel mass spectrometry-based method for simultaneous determination of asymmetric and symmetric dimethylarginine, l-arginine and l-citrulline optimized for LC-MS-TOF and LC-MS/MS.
    Wiśniewski J, Fleszar MG, Piechowicz J, Krzystek-Korpacka M, Chachaj A, Szuba A, Lorenc-Kukula K, Masłowski L, Witkiewicz W, Gamian A.
    Biomed Chromatogr; 2017 Nov 24; 31(11):. PubMed ID: 28436051
    [Abstract] [Full Text] [Related]

  • 5. L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery.
    Bednarz-Misa I, Fleszar MG, Zawadzki M, Kapturkiewicz B, Kubiak A, Neubauer K, Witkiewicz W, Krzystek-Korpacka M.
    J Clin Med; 2020 Jun 08; 9(6):. PubMed ID: 32521714
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA.
    Cardiovasc Diabetol; 2018 Jan 04; 17(1):1. PubMed ID: 29301528
    [Abstract] [Full Text] [Related]

  • 7. Circulating arginine metabolites in Alzheimer's disease and vascular dementia: A systematic review and meta-analysis.
    Zinellu A, Tommasi S, Sedda S, Mangoni AA.
    Ageing Res Rev; 2023 Dec 04; 92():102139. PubMed ID: 38007048
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive analysis of the L-arginine/L-homoarginine/nitric oxide pathway in preterm neonates: potential roles for homoarginine and asymmetric dimethylarginine in foetal growth.
    Buck A, Kayacelebi AA, Chobanyan-Jürgens K, Illsinger S, Bohnhorst B, Beckmann B, Hanff E, Das AM, Tsikas D, Lücke T.
    Amino Acids; 2017 Apr 04; 49(4):783-794. PubMed ID: 28161799
    [Abstract] [Full Text] [Related]

  • 9. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
    Bilgiç Ö, Altınyazar HC, Baran H, Ünlü A.
    Arch Dermatol Res; 2015 Jul 04; 307(5):439-44. PubMed ID: 25708188
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by NG-hydroxy-L-arginine, Nω,Nω-dimethyl-L-citrulline and Nω,Nω-dimethyl-Nδ-hydroxy-L-citrulline: results and overview.
    Bollenbach A, Tsikas D.
    Amino Acids; 2019 Mar 04; 51(3):483-494. PubMed ID: 30536052
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings.
    Krzystek-Korpacka M, Fleszar MG, Bednarz-Misa I, Lewandowski Ł, Szczuka I, Kempiński R, Neubauer K.
    Int J Mol Sci; 2020 Feb 28; 21(5):. PubMed ID: 32121248
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide synthesis capacity, ambulatory blood pressure and end organ damage in a black and white population: the SABPA study.
    Mels CMC, Loots I, Schwedhelm E, Atzler D, Böger RH, Schutte AE.
    Amino Acids; 2016 Mar 28; 48(3):801-810. PubMed ID: 26573539
    [Abstract] [Full Text] [Related]

  • 13. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Kulkarni P, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Respir Res; 2017 Jan 23; 18(1):25. PubMed ID: 28114935
    [Abstract] [Full Text] [Related]

  • 14. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb 23; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 15. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug 23; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
    Szlęzak D, Ufnal M, Drapała A, Samborowska E, Wróbel M.
    Amino Acids; 2023 Apr 23; 55(4):529-539. PubMed ID: 36802034
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the L-Arginine/Nitric Oxide Pathway and Oxidative Stress in Pediatric Patients with Atopic Diseases.
    Hanusch B, Sinningen K, Brinkmann F, Dillenhöfer S, Frank M, Jöckel KH, Koerner-Rettberg C, Holtmann M, Legenbauer T, Langrock C, Reinehr T, Maasjosthusmann P, Beckmann B, Hamelmann E, Tsikas D, Lücke T.
    Int J Mol Sci; 2022 Feb 15; 23(4):. PubMed ID: 35216250
    [Abstract] [Full Text] [Related]

  • 18. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S, Komáromy H, Kamson DO, Kovács N, Perlaki G, Orsi G, Molnár T, Illes Z, Nagy L, Kéki S, Deli G, Bosnyák E, Trauninger A, Pfund Z.
    Cephalalgia; 2017 May 15; 37(6):571-580. PubMed ID: 27206959
    [Abstract] [Full Text] [Related]

  • 19. Nitric Oxide-Related Biological Pathways in Patients with Major Depression.
    Baranyi A, Amouzadeh-Ghadikolai O, Rothenhäusler HB, Theokas S, Robier C, Baranyi M, Koppitz M, Reicht G, Hlade P, Meinitzer A.
    PLoS One; 2015 May 15; 10(11):e0143397. PubMed ID: 26581044
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ, Fickling SA, Whitley GS, Vallance P.
    Br J Pharmacol; 1994 May 15; 112(1):43-8. PubMed ID: 7518309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.